369 related articles for article (PubMed ID: 24927523)
1. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.
Mahdessian H; Taxiarchis A; Popov S; Silveira A; Franco-Cereceda A; Hamsten A; Eriksson P; van't Hooft F
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8913-8. PubMed ID: 24927523
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.
Ehrhardt N; Doche ME; Chen S; Mao HZ; Walsh MT; Bedoya C; Guindi M; Xiong W; Ignatius Irudayam J; Iqbal J; Fuchs S; French SW; Mahmood Hussain M; Arditi M; Arumugaswami V; Péterfy M
Hum Mol Genet; 2017 Jul; 26(14):2719-2731. PubMed ID: 28449094
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.
Smagris E; Gilyard S; BasuRay S; Cohen JC; Hobbs HH
J Biol Chem; 2016 May; 291(20):10659-76. PubMed ID: 27013658
[TBL] [Abstract][Full Text] [Related]
4. PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells.
Taxiarchis A; Mahdessian H; Silveira A; Fisher RM; Van't Hooft FM
J Lipid Res; 2019 Jun; 60(6):1069-1077. PubMed ID: 30918066
[TBL] [Abstract][Full Text] [Related]
5. TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
O'Hare EA; Yang R; Yerges-Armstrong LM; Sreenivasan U; McFarland R; Leitch CC; Wilson MH; Narina S; Gorden A; Ryan KA; Shuldiner AR; Farber SA; Wood GC; Still CD; Gerhard GS; Robishaw JD; Sztalryd C; Zaghloul NA
Hepatology; 2017 May; 65(5):1526-1542. PubMed ID: 28027591
[TBL] [Abstract][Full Text] [Related]
6. Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats.
Luo F; Smagris E; Martin SA; Vale G; McDonald JG; Fletcher JA; Burgess SC; Hobbs HH; Cohen JC
Cell Mol Gastroenterol Hepatol; 2022; 13(3):879-899. PubMed ID: 34923175
[TBL] [Abstract][Full Text] [Related]
7. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.
Borén J; Adiels M; Björnson E; Matikainen N; Söderlund S; Rämö J; Ståhlman M; Ripatti P; Ripatti S; Palotie A; Mancina RM; Hakkarainen A; Romeo S; Packard CJ; Taskinen MR
JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170809
[TBL] [Abstract][Full Text] [Related]
8. ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis.
Watanabe K; Watson E; Cremona ML; Millings EJ; Lefkowitch JH; Fischer SG; LeDuc CA; Leibel RL
PLoS One; 2013; 8(6):e67234. PubMed ID: 23826244
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of
Pant A; Chen Y; Kuppa A; Du X; Halligan BD; Speliotes EK
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575933
[TBL] [Abstract][Full Text] [Related]
10. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
Kozlitina J; Smagris E; Stender S; Nordestgaard BG; Zhou HH; Tybjærg-Hansen A; Vogt TF; Hobbs HH; Cohen JC
Nat Genet; 2014 Apr; 46(4):352-6. PubMed ID: 24531328
[TBL] [Abstract][Full Text] [Related]
11. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.
Luukkonen PK; Zhou Y; Nidhina Haridas PA; Dwivedi OP; Hyötyläinen T; Ali A; Juuti A; Leivonen M; Tukiainen T; Ahonen L; Scott E; Palmer JM; Arola J; Orho-Melander M; Vikman P; Anstee QM; Olkkonen VM; Orešič M; Groop L; Yki-Järvinen H
J Hepatol; 2017 Jul; 67(1):128-136. PubMed ID: 28235613
[TBL] [Abstract][Full Text] [Related]
12. TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease.
Luo F; Oldoni F; Das A
Hepatol Commun; 2022 Mar; 6(3):448-460. PubMed ID: 34532996
[TBL] [Abstract][Full Text] [Related]
13. TM6SF2: A novel target for plasma lipid regulation.
Li TT; Li TH; Peng J; He B; Liu LS; Wei DH; Jiang ZS; Zheng XL; Tang ZH
Atherosclerosis; 2018 Jan; 268():170-176. PubMed ID: 29232562
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.
Fan Y; Lu H; Guo Y; Zhu T; Garcia-Barrio MT; Jiang Z; Willer CJ; Zhang J; Chen YE
Gastroenterology; 2016 May; 150(5):1208-1218. PubMed ID: 26774178
[TBL] [Abstract][Full Text] [Related]
15. Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism.
Liu J; Ginsberg HN; Reyes-Soffer G
Curr Opin Lipidol; 2024 Jun; 35(3):157-161. PubMed ID: 38465912
[TBL] [Abstract][Full Text] [Related]
16. Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells.
Ruhanen H; Nidhina Haridas PA; Eskelinen EL; Eriksson O; Olkkonen VM; Käkelä R
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jul; 1862(7):676-685. PubMed ID: 28434889
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
18. TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression.
Li TT; Cui YT; Li TH; Xiang Q; Chen YY; Zheng XL; Peng J; Tang ZH
Exp Cell Res; 2023 Aug; 429(2):113666. PubMed ID: 37271250
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
20. A functional, genome-wide evaluation of liposensitive yeast identifies the "ARE2 required for viability" (ARV1) gene product as a major component of eukaryotic fatty acid resistance.
Ruggles KV; Garbarino J; Liu Y; Moon J; Schneider K; Henneberry A; Billheimer J; Millar JS; Marchadier D; Valasek MA; Joblin-Mills A; Gulati S; Munkacsi AB; Repa JJ; Rader D; Sturley SL
J Biol Chem; 2014 Feb; 289(7):4417-31. PubMed ID: 24273168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
